Clinilabs Drug Development Corporation is a global, full-service Contract Research Organization (CRO) specializing in central nervous system (CNS) drug development. With a focus on neurological disorders, substance use disorders, rare CNS disorders, and mental health disorders, Clinilabs is dedicated to bringing new therapies to patients in need. Their experience, scientific knowledge, and operational expertise ensure accountability, responsibility, and integrity in every phase of drug development.
As the only CRO exclusively focused on CNS drug development, Clinilabs fills a significant unmet need in the pharmaceutical and biotechnology industry. From first-in-human to Phase 3 trials, they offer a complete range of services to support the development of CNS drugs. With a commitment to improving the lives of patients, Clinilabs combines expertise with cutting-edge technology to advance the field of CNS drug development.
Generated from the website